Improvement of Quality of Life in Patients Using Low-dose Pills in the Different Phases of Menacme

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01174524

Enrollment

100

Registered

2010-08-03

Start date

2008-01-31

Completion date

2008-11-30

Last updated

2010-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception, Menopause, Quality of Life

Keywords

Quality of life, Menopause, Contraception

Brief summary

The purpose of this study is to determine whether low-dose contraceptive pills are effective in the improvement of quality of life in patients in the different phases of menacme.

Interventions

DRUGgestoden 60 mcg

gestoden 60 mcg, once a day, administered in 24/4 regimen.

DRUGethinylestradiol 15 mcg

ethinylestradiol 15 mcg, once a day, administered in 24/4 regimen

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

15 Years to 46 Years

Healthy volunteers

Yes

Inclusion criteria

* Fertile women with indication of use of contraceptive pills

Exclusion criteria

* Fertile women with any surgical contraceptive method * Women in menopause * Diseases the forbidden the use of the drug

Design outcomes

Primary

Measure	Time frame
Quality of life	eleven months

Secondary

Measure	Time frame
Quality of life in differents phases of menacme	eleven months

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026